Neurobiology of Aging
Volume 30, Issue 10 , Pages 1563-1573 , October 2009

JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1

  • Elena Tamagno

      Affiliations

    • Department of Experimental Medicine and Oncology, University of Turin, Turin, Italy
    • Corresponding Author InformationCorresponding author at: University of Turin, Department of Experimental Medicine and Oncology, Corso Raffaello 30, 10125 Turin, Italy. Tel.: +39 0116707763; fax: +39 0116707763.
    • ,
  • Michela Guglielmotto

      Affiliations

    • Department of Experimental Medicine and Oncology, University of Turin, Turin, Italy
    • ,
  • Luca Giliberto

      Affiliations

    • Department of Neurosciences, Ophtalmology and Genetics, University of Genoa, Genoa, Italy
    • ,
  • Antonella Vitali

      Affiliations

    • Department of Neurosciences, Ophtalmology and Genetics, University of Genoa, Genoa, Italy
    • ,
  • Roberta Borghi

      Affiliations

    • Department of Neurosciences, Ophtalmology and Genetics, University of Genoa, Genoa, Italy
    • ,
  • Riccardo Autelli

      Affiliations

    • Department of Experimental Medicine and Oncology, University of Turin, Turin, Italy
    • ,
  • Oliviero Danni

      Affiliations

    • Department of Experimental Medicine and Oncology, University of Turin, Turin, Italy
    • ,
  • Massimo Tabaton

      Affiliations

    • Department of Neurosciences, Ophtalmology and Genetics, University of Genoa, Genoa, Italy
    • Corresponding Author InformationCorresponding author at: University of Genoa, Department of Neurosciences, Via de Toni 2, 16132 Genoa, Italy. Tel.: +39 0103537064; fax: +39 010506938.

Received 12 November 2007 ,Revised 17 December 2007 ,Accepted 19 December 2007.

References 

  1. Amadoro G, Pieri M, Ciotti MT, Carunchio I, Canu N, Calissano P, et al. Substance P provides neuroprotection in cerebellar granule cells through Akt and MAPK/Erk activation: evidence for the involvement of the delayed rectifier potassium current. Neuropharmacology. 2007;52:1366–1377
  2. Borghi R, Patriarca S, Traverso N, Piccini A, Storace D, Garuti A, et al. The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease. Neurobiol. Aging. 2007;28:1009–1014
  3. Canet-Aviles RM, Anderton M, Hooper NM, Turner AJ, Vaughan PF. Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(alpha), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase C. Brain Res. Mol. Brain Res. 2002;102:62–72
  4. Chong ZZ, Maiese K. Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histol. Histopathol. 2004;19:495–504
  5. Chong ZZ, Kang JQ, Maiese K. Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. Antioxid. Redox Signal. 2004;6:277–287
  6. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 1997;3:67–72
  7. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2004;101:2070–2075
  8. Desdouits-Magnen J, Desdouits F, Takeda S, Syu LJ, Saltiel AR, Buxbaum JD, et al. Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J. Neurochem. 1998;70:524–530
  9. Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 1998;273:32377–32379
  10. Fukumoto H, Cheung BS, Hyman BT, Irizzary MC. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 2002;59:1381–1389
  11. Guerra B, Diaz M, Alonso R, Marin R. Plasma membrane oestrogen receptor mediates neuroprotection against beta-amyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cells. J. Neurochem. 2004;91:99–109
  12. Holsinger RMD, McLean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor β-secretase in Alzheimer's disease. Ann. Neurol. 2002;51:783–786
  13. Hu MC, Qiu WR, Wang X, Meyer CF, Tan TH. Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade. Genes Dev. 1996;1:2251–2264
  14. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr. Biol. 1999;9:601–604
  15. Kanzawa T, Iwado E, Aoki H, Iwamaru A, Hollingsworth EF, Sawaya R, et al. Ionizing radiation induces apoptosis and inhibits neuronal differentiation in rat neural stem cells via the c-Jun NH2-terminal kinase (JNK) pathway. Oncogene. 2006;25:3638–3648
  16. Kao SC, Krichevsky AM, Kosik KS, Tsai LH. BACE1 suppression by RNA interference in primary cortical neurons. J. Biol. Chem. 2004;279:1942–1949
  17. Kilic U, Kilic E, Jarve A, Guo Z, Spudich A, Bieber K, et al. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J. Neurosci. 2006;26:12439–12446
  18. Kim AH, Khursigara G, Sun X, Franke TF, Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 2001;21:893–901
  19. Kim SK, Park HJ, Hong HS, Baik EJ, Jung MW, Mook-Jung I. ERK1/2 is an endogenous negative regulator of the gamma-secretase activity. FASEB J. 2005;20:157–159
  20. Knaus UG, Bokoch GM. The p21Rac/Cdc42-activated kinases (PAKs). Int. Biochem. Cell Biol. 1998;30:857–862
  21. Kwon T, Kwon DY, Chun J, Kim JH, Kang SS. Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1. J. Biol. Chem. 2000;275:423–428
  22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;277:680–685
  23. Lagalwar S, Guillozet-Bongaarts AL, Berry RW, Binder LI. Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006;65:455–464
  24. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta42 deposition and severe cerebellar pathology. Nat. Med. 1996;2:1146–1150
  25. Levresse V, Butterfield L, Zentrich E, Heasley LE. Akt negatively regulates the cJun N-terminal kinase pathway in PC12 cells. J. Neurosci. Res. 2000;62:799–808
  26. Liu F, Su Y, Li B, Ni B. Regulation of amyloid precursor protein expression and secretion via activation of ERK1/2 by hepatocyte growth factor in HEK293 cells transfected with APP751. Exp. Cell Res. 2003;287:387–396
  27. Marambaud P, Wen PH, Dutt A, Shioi J, Takashima A, Siman R, et al. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell. 2003;114:635–645
  28. Mei M, Su B, Harrison K, Chao M, Siedlack SL, Previll LA, et al. Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease. J. Neurochem. 2006;99:1377–1388
  29. Mills J, Laurent Charest D, Lam F, Beyreuther K, Ida N, Pelech SL, et al. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 1997;17:9415–9422
  30. Nizzari M, Venezia V, Repetto E, Corsi V, Magrassi R, Gagliani MC, et al. Amyloid precursor protein and presenilin 1 interact with the adaptor GRB2 and modulate ERK1 2 signaling. J. Biol. Chem. 2007;282:13833–13844
  31. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001;60:759–767
  32. Otth C, Mendoza-Naranjo A, Mujica L, Zambiano A, Concha II, Maccioni RB. Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease. Neuroreport. 2003;14:2403–2409
  33. Pearson AG, Byrne UT, MacGibbon GA, Faull RL, Dragunow M. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Neurosci. Lett. 2006;398:246–250
  34. Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K, et al. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res. Mol. Brain Res. 2002;109:45–55
  35. Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, et al. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. NeuroReport. 1999;10:2411–2415
  36. Pugazhenthi S, Phansalkar K, Audesirk G, West A, Cabell L. Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal. Free Radic. Biol. Med. 2006;40:21–34
  37. Puig B, Gomez-Isla T, Ribe E, Cuadrado M, Torrejon-Escribano B, Dalfo E, et al. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding beta plaques in APP Tg2576 mice. Neuropathol. Appl. Neurobiol. 2004;30:491–502
  38. Savage MJ, Lin YG, Ciallella JR, Flood DG, Scott RW. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 2002;22:3376–3385
  39. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001;81:741–766
  40. Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, et al. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 2002;10:279–288
  41. Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, et al. Multiple signaling events in amyloid β-induced, oxidative stress-dependent neuronal apoptosis. Free Radic. Biol. Med. 2003;35:45–58
  42. Tamagno E, Guglielmotto M, Bardini P, Santoro G, Davit A, Di Simone D, et al. Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress. Neurobiol. Dis. 2003;14:291–301
  43. Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, et al. β-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 2005;92:628–636
  44. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, et al. Oxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor protein. J. Neurochem. 2008;104:683–695
  45. Tatebayashi Y, Planel E, Chui DH, Sato S, Miyasaka T, Sahara N, et al. C-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis. FASEB J. 2006;20:762–764
  46. Thakur A, Wang X, Siedlak SL, Perry G, Smith MA, Zhu XJ. c-Jun phosphorylation in Alzheimer disease. Neurosci. Res. 2007;85:1668–1673
  47. Tong Y, Zhou W, Fung V, Christensen MA, Qing H, Sun H, et al. Oxidative stress potentiates BACE1 gene expression and Abeta generation. Neural Transm. 2005;112:455–469
  48. Uemura K, Kihara T, Kuzuya A, Okawa A, Nishimoto T, Ninomiya H, et al. Characterization of sequential N-cadherin cleavage by ADAM10 and PS1. Neurosci. Lett. 2006;402:278–283
  49. Watson K, Fan GH. Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1–42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol. Pharmacol. 2005;67:757–765
  50. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, et al. Elevated β-secretase expression and activity detected in sporadic Alzheimer disease. Nat. Med. 2003;9:3
  51. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;1407:802–809
  52. Zhang QG, Wu DN, Han D, Zhang GY. Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury. FEBS Lett. 2007;581:495–505
  53. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, et al. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 2001;76:435–741
  54. Zhu X, Lee HG, Raina AK, Perry G, Smith MA. The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals. 2002;11:270–281
  55. Zhu X, Ogawa O, Wang Y, Perry G, Smith MA. JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease. J. Neurochem. 2003;85:87–93
  56. Zhu X, Raina AK, Lee HG, Chao M, Nunomura A, Tabaton M, et al. Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. Antioxid. Redox Signal. 2003;5:571–576
  57. Zhu X, Sun Z, Lee H, Siedlack SL, Perry G, Smith MA. Distribution, levels and activation of MEK1 in Alzheimer's disease. J. Neurochem. 2003;86:136–142

PII: S0197-4580(07)00494-0

doi: 10.1016/j.neurobiolaging.2007.12.015

Neurobiology of Aging
Volume 30, Issue 10 , Pages 1563-1573 , October 2009

Article Tools

* Image Usage & Resolution